FI972929A0 - Methods and compositions based on collagen for the treatment of diseases mediated by the immune system - Google Patents

Methods and compositions based on collagen for the treatment of diseases mediated by the immune system

Info

Publication number
FI972929A0
FI972929A0 FI972929A FI972929A FI972929A0 FI 972929 A0 FI972929 A0 FI 972929A0 FI 972929 A FI972929 A FI 972929A FI 972929 A FI972929 A FI 972929A FI 972929 A0 FI972929 A0 FI 972929A0
Authority
FI
Finland
Prior art keywords
collagen
treatment
methods
immune system
compositions based
Prior art date
Application number
FI972929A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI972929A (en
Inventor
Thomas B Neff
George R Martin
Karl A Piez
Taina A Pihlajaniemi
Kari I Kivirikko
Original Assignee
Fibrogen Inc
Academy Of Finland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fibrogen Inc, Academy Of Finland filed Critical Fibrogen Inc
Publication of FI972929A0 publication Critical patent/FI972929A0/en
Publication of FI972929A publication Critical patent/FI972929A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
FI972929A 1995-01-10 1997-07-10 Methods and compositions based on collagen for the treatment of diseases mediated by the immune system FI972929A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37038895A 1995-01-10 1995-01-10
PCT/US1996/000533 WO1996021458A1 (en) 1995-01-10 1996-01-11 Collagen-based methods and formulations for the treatment of immune system-mediated diseases

Publications (2)

Publication Number Publication Date
FI972929A0 true FI972929A0 (en) 1997-07-10
FI972929A FI972929A (en) 1997-09-10

Family

ID=23459429

Family Applications (1)

Application Number Title Priority Date Filing Date
FI972929A FI972929A (en) 1995-01-10 1997-07-10 Methods and compositions based on collagen for the treatment of diseases mediated by the immune system

Country Status (10)

Country Link
EP (1) EP0805686A1 (en)
JP (1) JPH10512554A (en)
AU (1) AU4657096A (en)
BR (1) BR9606753A (en)
CA (1) CA2210088A1 (en)
FI (1) FI972929A (en)
HU (1) HUP9800829A3 (en)
MX (1) MX9705198A (en)
NO (1) NO973193L (en)
WO (1) WO1996021458A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5856446A (en) * 1995-07-07 1999-01-05 Autoimmune Inc. Method of treating rheumatoid arthritis with low dose type II collagen
US6391303B1 (en) * 1996-11-18 2002-05-21 Emisphere Technologies, Inc. Methods and compositions for inducing oral tolerance in mammals
US7097845B2 (en) 1997-04-23 2006-08-29 Jacob Sten Petersen Combinations of antigen and mucosal binding component for inducing specific immunological tolerance
DE19804210A1 (en) 1998-02-03 1999-08-12 Biosyn Arzneimittel Gmbh Recombinant mistletoe lectins
EP1105051A4 (en) * 1998-08-10 2003-08-06 Fibrogen Inc Collagen type i and type iii hemostatic compositions for use as a vascular sealant and wound dressing
KR102577697B1 (en) * 2019-11-13 2023-09-14 주식회사 나이벡 Peptides for Inflammation Treatment and Wound healing
BR112022011557A2 (en) * 2019-12-12 2022-08-30 Ineb Inst De Engenharia Biomedica DECELLULARIZED FETAL MATERIAL FROM THE PULPUS NUCLEUS AND METHODS FOR OBTAINING PHARMACEUTICAL COMPOSITIONS TO BE USED IN THE TREATMENT OF INTERVERTEBRAL DISC DEGENERATION AND BACK PAIN
DE102021214899A1 (en) * 2021-12-22 2023-06-22 Gelita Ag Type I collagen peptide for use in therapy
JP7357189B1 (en) * 2022-07-14 2023-10-06 株式会社リナイス Collagen-containing composition derived from fish cartilage

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5399347A (en) * 1987-06-24 1995-03-21 Autoimmune, Inc. Method of treating rheumatoid arthritis with type II collagen

Also Published As

Publication number Publication date
NO973193L (en) 1997-09-09
WO1996021458A1 (en) 1996-07-18
AU4657096A (en) 1996-07-31
CA2210088A1 (en) 1996-07-18
NO973193D0 (en) 1997-07-09
MX9705198A (en) 1997-12-31
EP0805686A1 (en) 1997-11-12
HUP9800829A3 (en) 1999-09-28
FI972929A (en) 1997-09-10
JPH10512554A (en) 1998-12-02
HUP9800829A2 (en) 1998-07-28
BR9606753A (en) 1998-01-06

Similar Documents

Publication Publication Date Title
FI971969A (en) Compositions for the treatment of hemorrhoids and method of use
DE69631531D1 (en) CATHETER FOR CHARACTERIZING MEDICINAL PRODUCTS
FI952926A0 (en) Procedures for the treatment and prevention of all Procedures for the treatment and prevention of allergies ergies
ATE235481T1 (en) SUBSTITUTED BENZOPYRANE DERIVATIVES FOR THE TREATMENT OF INFLAMMATION
FI20090217A (en) Process for the preparation of food compositions
FI970918A0 (en) Compounds and methods for the treatment of cancer
FI960278A (en) Process for the preparation of anatastitanium dioxide
FI954383A (en) Process for the preparation of cancer vaccines
FI990171A0 (en) New compounds and compositions for the treatment of diseases dependent on tryptase activity
FI962370A0 (en) Apparatus for the manufacture of tissue
FI942907A (en) Process for the preparation of lipase
NO974257D0 (en) Immunomodulatory bile preparations for the treatment of immune system disorders
AU7363691A (en) Methods for treating interleukin-1 mediated diseases
FI972929A0 (en) Methods and compositions based on collagen for the treatment of diseases mediated by the immune system
DE59611266D1 (en) Process for the preparation of flavano lignan preparations
AU9395998A (en) Compositions and methods for the treatment of immune related diseases
FI955161A0 (en) System for controlled release of pilocarpine
FI964229A0 (en) Process for the preparation of doxorubicin
NO913117D0 (en) PROCEDURE FOR THE TREATMENT OF NECESSARY DISEASES.
FI956058A (en) Process for the preparation of glutardialdehyde
FI955777A (en) Procedure and product range for performing hair treatment
NO973366D0 (en) Procedure for the treatment of multiple sclerosis
FI963947A (en) Completely dissolved bone tissue and procedure for making the same
FI943213A (en) Process for the preparation of 3-acyl esters and acylbenzenes
DE69509082T2 (en) Process for the preparation of oligomers of mono-olefins